December 12, 2017
A Georgia federal jury on Monday sided with the U.S. Securities and Exchange Commission and found that medical device maker Revolutions Medical Corp. and its top executive issued false statements to pump up its stock price.
September 21, 2012
The U.S. Securities and Exchange Commission sued Revolutions Medical Corp. in Georgia federal court on Thursday, accusing the medical device maker of issuing false press statements about its flagship product, a retractable medical syringe, to artificially inflate its stock price.